Skip to content
Open access · CC-BY via OpenAlex

The role of DNA methylation in epigenetics of aging

Archana Unnikrishnan, Willard M. Freeman, Jordan Jackson, Jonathan D. Wren, Hunter L. Porter, Arlan Richardson

Pharmacology & Therapeutics · 2018 · ▲ 392 citations

Abstract

Recent research suggests that epigenetics, especially DNA methylation, plays a mechanistic role in aging. Epigenetic clocks, which measure changes in a few hundred specific CpG sites, can accurately predict chronological age in a variety of species, including humans. These clocks are currently the best biomarkers for predicting mortality in humans. Additionally, several studies have characterized the effects of aging across the methylome in a wide variety of tissues from humans and mice. A small fraction (~2%) of the CpG sites show age-related changes, either hypermethylation or hypomethylation with aging. Evaluation of non-CpG site methylation has only been examined in a few studies, with about ~0.5% of these sites showing a change with age. Therefore, while only a small fraction of cytosines in the genome show changes in DNA methylation with age, this represents 2 to 3 million cytosines in the genome. Importantly, the only study to compare the effect of aging on DNA methylation in male and female mice and humans found that >95% of the age-related changes in DNA methylation in the hippocampus were sexually divergent, i.e., the methylation did not differ between males and females at young age but age-related changes occurred in one sex but not the other. The age-related changes in DNA methylation tend to be enriched and under-represented in specific genomic contexts, with some commonalities between tissues and species that require further investigation. The strongest evidence that the age-related changes in DNA methylation play a role in aging comes from studies of anti-aging interventions (e.g., caloric restriction(definition), dwarfism, and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) treatment) in mice. These anti-aging interventions deaccelerate the epigenetic clocks and reverse/prevent 20 to 40% of the age-related changes in DNA methylation. It will be important in the future to demonstrate that at least some of the age-related changes in DNA methylation directly lead to alterations in the transcriptome of cells/tissues that could potentially contribute to aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.pharmthera.2018.11.001
Canonical
link ↗
Fetched
2026-06-02 MST

Cite this

APA
Unnikrishnan, A., Freeman, W.M., Jackson, J., Wren, J.D., Porter, H.L., &amp; Richardson, A. (2018). The role of DNA methylation in epigenetics of aging. <em>Pharmacology & Therapeutics</em>. https://doi.org/10.1016/j.pharmthera.2018.11.001
Vancouver
Unnikrishnan A, Freeman WM, Jackson J, Wren JD, Porter HL, Richardson A. The role of DNA methylation in epigenetics of aging. Pharmacology & Therapeutics. 2018. doi:10.1016/j.pharmthera.2018.11.001.
BibTeX
@article{archana2018Therol, title = {The role of DNA methylation in epigenetics of aging}, author = {Archana Unnikrishnan and Willard M. Freeman and Jordan Jackson and Jonathan D. Wren and Hunter L. Porter and Arlan Richardson}, journal = {Pharmacology & Therapeutics}, year = {2018}, doi = {10.1016/j.pharmthera.2018.11.001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings